Ontology highlight
ABSTRACT:
SUBMITTER: Freedman MS
PROVIDER: S-EPMC3948518 | biostudies-literature | 2014 Mar
REPOSITORIES: biostudies-literature
Freedman Mark S MS De Stefano Nicola N Barkhof Frederik F Polman Chris H CH Comi Giancarlo G Uitdehaag Bernard M J BM Casset-Semanaz Florence F Hennessy Brian B Lehr Lorenz L Stubinski Bettina B Jack Dominic L DL Kappos Ludwig L
Journal of neurology 20140112 3
The REFLEX study (NCT00404352) established that subcutaneous (sc) interferon (IFN) β-1a reduced the risks of McDonald MS (2005 criteria) and clinically definite multiple sclerosis (CDMS) in patients with a first clinical demyelinating event suggestive of MS. The aim of this subgroup analysis was to assess the treatment effect of sc IFN β-1a in patient subgroups defined by baseline disease and demographic characteristics (age, sex, use of steroids at the first event, classification of first event ...[more]